Literature DB >> 12759433

Normal somatic hypermutation of Ig genes in the absence of 8-hydroxyguanine-DNA glycosylase.

David B Winter1, Quy H Phung, Xianmin Zeng, Erling Seeberg, Deborah E Barnes, Tomas Lindahl, Patricia J Gearhart.   

Abstract

The hypermutation cascade in Ig V genes can be initiated by deamination of cytosine in DNA to uracil by activation-induced cytosine deaminase and its removal by uracil-DNA glycosylase. To determine whether damage to guanine also contributes to hypermutation, we examined the glycosylase that removes oxidized guanine from DNA, 8-hydroxyguanine-DNA glycosylase (OGG1). OGG1 has been reported to be overexpressed in human B cells from germinal centers, where mutation occurs, and could be involved in initiating Ab diversity by removing modified guanines. In this study, mice deficient in Ogg1 were immunized, and V genes from the H and kappa L chain loci were sequenced. Both the frequency of mutation and the spectra of nucleotide substitutions were similar in ogg1(-/-) and Ogg1(+/+) clones. More importantly, there was no significant increase in G:C to T:A transversions in the ogg1(-/-) clones, which would be expected if 8-hydroxyguanine remained in the DNA. Furthermore, Ogg1 was not up-regulated in murine B cells from germinal centers. These findings show that hypermutation is unaffected in the absence of Ogg1 activity and indicate that 8-hydroxyguanine lesions most likely do not cause V gene mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759433     DOI: 10.4049/jimmunol.170.11.5558

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  The DNA glycosylases Ogg1 and Nth1 do not contribute to Ig class switching in activated mouse splenic B cells.

Authors:  Anna J Ucher; Erin K Linehan; George W Teebor; Carol E Schrader; Janet Stavnezer
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 2.  Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences.

Authors:  Maria Stratigopoulou; Tijmen P van Dam; Jeroen E J Guikema
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.